XML 45 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
REVENUE $ 108 $ 498
OPERATING EXPENSES:    
Research and development expenses 1,954 741
Selling and marketing expenses 1,201 639
General and administration expenses 6,133 2,196
Impairment of intangible assets 874 0
TOTAL OPERATING EXPENSES 10,162 3,576
OPERATING LOSS (10,054) (3,078)
OTHER INCOME (EXPENSE)    
Interest and bank fees (69) (18)
Foreign exchange gain 11 37
Change in derivative fair value (156) 0
Other income (expenses) (190) 457
TOTAL OTHER INCOME (EXPENSE) (404) 476
LOSS BEFORE INCOME TAX (10,458) (2,602)
Income tax provision (2) (1)
NET LOSS AND COMPREHENSIVE LOSS $ (10,460) $ (2,603)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share) $ (1.6) $ (0.81)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING, BASIC AND DILUTED (in shares) 6,546,769 3,233,270